{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T21:57:33Z","timestamp":1784152653111,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"16","license":[{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100021704","name":"Administration for Strategic Preparedness and Response","doi-asserted-by":"crossref","award":["Contract Number 75FCMC18D0047 Task Order\u202f75A50121F80012"],"award-info":[{"award-number":["Contract Number 75FCMC18D0047 Task Order\u202f75A50121F80012"]}],"id":[{"id":"10.13039\/100021704","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s11606-023-08324-y","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T19:08:17Z","timestamp":1694804897000},"page":"3472-3481","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Influence of Social Determinants on Receiving Outpatient Treatment with Monoclonal Antibodies, Disease Risk, and Effectiveness for COVID-19"],"prefix":"10.1007","volume":"38","author":[{"given":"Nalini","family":"Ambrose","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpesh","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Bertagnolli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0757-9305","authenticated-orcid":false,"given":"Francis","family":"Campion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Danan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"D\u2019Arinzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Drews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Erlandson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fraser","family":"Gaspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlene","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Hawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert","family":"Lopansri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ty","family":"Mullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Musser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"O\u2019Horo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Piantadosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobbi","family":"Pritt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymund","family":"Razonable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Rele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Sandmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerez","family":"Te","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhaan","family":"Vahidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Welch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Yttri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,15]]},"reference":[{"key":"8324_CR1","unstructured":"World Health Organization. COVID-19 and the social determinants of health and health equity: evidence brief [Internet]. Geneva: World Health Organization; 2021 [cited 2022 Nov 7]. Available from: https:\/\/apps.who.int\/iris\/handle\/10665\/348333."},{"key":"8324_CR2","unstructured":"Centers for Disease Control and Prevention. Outpatient Use of COVID-19 Medication [Internet]. 2022 [cited 2022 Nov 22];Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/science\/data-review\/evidence.html."},{"key":"8324_CR3","unstructured":"FDA. FDA Fact Sheet for Health Care Providers Emergency Use Authorization (EUA) of Sotrovimab. [Internet]. 2022 [cited 2022 Apr 11];Available from: https:\/\/www.fda.gov\/media\/149534\/download."},{"key":"8324_CR4","unstructured":"FDA. FDA Fact Sheet for Health Care Providers Emergency Use Authorization (EUA) of REGEN-COV\u00ae (casirivimab and imdevimab) [Internet]. 2021 [cited 2022 Apr 11];Available from: https:\/\/www.fda.gov\/media\/145611\/download."},{"key":"8324_CR5","unstructured":"FDA. FDA Fact Sheet for Health Care Providers Emergency Use Authorization (EUA) of bamlanivimab and etesevimab. 2022 [cited 2022 Apr 11];Available from: https:\/\/www.fda.gov\/media\/145802\/download."},{"key":"8324_CR6","unstructured":"Administration of Strategic Preparedness & Response. State\/Territory-Coordinated Distribution of COVID-19 Therapeutics [Internet]. 2022 [cited 2022 Nov 1];Available from: https:\/\/aspr.hhs.gov\/COVID-19\/Therapeutics\/Distribution\/Pages\/default.aspx."},{"key":"8324_CR7","unstructured":"CDC. Underlying Medical Conditions Associated with Higher Risk for Severe COVID-19: Information for Healthcare Professionals [Internet]. Cent. Dis. Control Prev. 2020 [cited 2022 Jun 13];Available from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/clinical-care\/underlyingconditions.html."},{"key":"8324_CR8","doi-asserted-by":"publisher","unstructured":"Sakata T, Brunisholz KD, Andersen C, Davie D, Srivastava R, Webb BJ. The MAb Squad: Delivering Covid-19 Monoclonal Antibody Therapy Across a Large Geographic Region. NEJM Catal [Internet] 2021 [cited 2022 Sep 9];2(9):CAT.21.0154. Available from: http:\/\/catalyst.nejm.org\/doi\/https:\/\/doi.org\/10.1056\/CAT.21.0154.","DOI":"10.1056\/CAT.21.0154"},{"key":"8324_CR9","doi-asserted-by":"crossref","unstructured":"Bierle DM, Ganesh R, Wilker CG, et al. Influence of Social and Cultural Factors on the Decision to Consent for Monoclonal Antibody Treatment among High-Risk Patients with Mild-Moderate COVID-19. J Prim Care Community Health [Internet] 2021 [cited 2021 Oct 19];12:21501327211019280. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34032171\/.","DOI":"10.1177\/21501327211019282"},{"key":"8324_CR10","doi-asserted-by":"crossref","unstructured":"Boehmer TK, Koumans EH, Skillen EL, et al. Racial and Ethnic Disparities in Outpatient Treatment of COVID-19 \u2013 United States, January\u2013July 2022. MMWR Morb Mortal Wkly Rep [Internet] 2022 [cited 2022 Oct 28];71(43):1359\u201365. Available from: http:\/\/www.cdc.gov\/mmwr\/volumes\/71\/wr\/mm7143a2.htm?s_cid=mm7143a2_w.","DOI":"10.15585\/mmwr.mm7143a2"},{"key":"8324_CR11","doi-asserted-by":"crossref","unstructured":"Wiltz JL, Feehan AK, Molinari NM, et al. Racial and Ethnic Disparities in Receipt of Medications for Treatment of COVID-19 \u2014 United States, March 2020\u2013August 2021. MMWR Morb Mortal Wkly Rep [Internet] 2022 [cited 2022 Nov 1];71(3):96\u2013102. Available from: http:\/\/www.cdc.gov\/mmwr\/volumes\/71\/wr\/mm7103e1.htm?s_cid=mm7103e1_w.","DOI":"10.15585\/mmwr.mm7103e1"},{"key":"8324_CR12","doi-asserted-by":"publisher","unstructured":"Wu E-L, Kumar RN, Moore WJ, et al. Disparities in COVID-19 Monoclonal Antibody Delivery: a Retrospective Cohort Study. J Gen Intern Med [Internet] 2022 [cited 2022 Nov 1];37(10):2505\u201313. Available from: https:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s11606-022-07603-4.","DOI":"10.1007\/s11606-022-07603-4"},{"key":"8324_CR13","unstructured":"National Institute of Health. Anti-SARS-CoV-2 Monoclonal Antibodies [Internet]. COVID-19 Treat. Guidel. 2022 [cited 2022 Mar 7];Available from: https:\/\/www.covid19treatmentguidelines.nih.gov\/therapies\/anti-sars-cov-2-antibody-products\/anti-sars-cov-2-monoclonal-antibodies\/."},{"key":"8324_CR14","unstructured":"United States Census Bureau. 2019 American Community Survey. [cited 2022 Feb 18];Available from: https:\/\/www.census.gov\/acs\/www\/data\/data-tables-and-tools\/data-profiles\/."},{"issue":"26","key":"8324_CR15","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1056\/NEJMp1802313","volume":"378","author":"AJH Kind","year":"2018","unstructured":"Kind AJH, Buckingham WR. Making Neighborhood-Disadvantage Metrics Accessible \u2014 The Neighborhood Atlas. N Engl J Med [Internet] 2018 [cited 2022 Mar 4];378(26):2456\u20138. Available from: https:\/\/doi.org\/10.1056\/NEJMp1802313.","journal-title":"N Engl J Med"},{"key":"8324_CR16","unstructured":"University of Wisconsin School of Medicine and Public Health. 2019. Area Deprivation Index, Version 3.1 [Internet]. [cited 2022 Feb 28];Available from: https:\/\/www.neighborhoodatlas.medicine.wisc.edu."},{"key":"8324_CR17","unstructured":"AHRQ. Elixhauser Comorbidity Software Refined for ICD-10-CM diagnosis, v2022.1. 2021;Available from: https:\/\/www.hcup-us.ahrq.gov\/toolssoftware\/comorbidityicd10\/CMR-User-Guide-v2022-1.pdf. Accessed\u00a02022 Dec 2"},{"key":"8324_CR18","doi-asserted-by":"publisher","unstructured":"Belitser SV, Martens EP, Pestman WR, Groenwold RHH, de Boer A, Klungel OH. Measuring balance and model selection in propensity score methods. Pharmacoepidemiol Drug Saf [Internet] 2011 [cited 2021 Nov 9];20(11):1115\u201329. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/abs\/https:\/\/doi.org\/10.1002\/pds.2188.","DOI":"10.1002\/pds.2188"},{"key":"8324_CR19","doi-asserted-by":"crossref","unstructured":"Stuart EA, Lee BK, Leacy FP. Prognostic score\u2013based balance measures can be a useful diagnostic for propensity score methods in comparative effectiveness research. J Clin Epidemiol [Internet] 2013 [cited 2022 Mar 11];66(8):S84-S90.e1. Available from: https:\/\/www.jclinepi.com\/article\/S0895-4356(13)00162-5\/fulltext.","DOI":"10.1016\/j.jclinepi.2013.01.013"},{"key":"8324_CR20","doi-asserted-by":"crossref","unstructured":"van Buuren S, Groothuis-Oudshoorn K. mice: Multivariate Imputation by Chained Equations in R. J Stat Softw [Internet] 2011 [cited 2021 Dec 10];45(3):1\u201367. Available from: https:\/\/www.jstatsoft.org\/index.php\/jss\/article\/view\/v045i03.","DOI":"10.18637\/jss.v045.i03"},{"key":"8324_CR21","doi-asserted-by":"crossref","unstructured":"Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York: John Wiley & Sons; 1987. [cited 2022 Nov 15].","DOI":"10.1002\/9780470316696"},{"key":"8324_CR22","unstructured":"R B, G L, H T, BrownewellVicki. Rapid Operationalization of Covid-19 Monoclonal Antibody Infusion Clinics. NEJM Catal Innov Care Deliv [Internet]. 2021 Mar 29 [cited 2022 Oct 5]; Available from: https:\/\/catalyst.nejm.org\/doi\/full\/10.1056\/CAT.21.0040."},{"key":"8324_CR23","unstructured":"Razonable RR, Aloia NCE, Anderson RJ, et al. A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19. Mayo Clin Proc [Internet] 2021 [cited 2022 Nov 7];96(5):1250\u201361. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619621001919."},{"key":"8324_CR24","doi-asserted-by":"crossref","unstructured":"Castro AD, Mayr FB, Talisa VB, et al.\u00a0 Variation in Clinical Treatment and Outcomes by Race Among US Veterans Hospitalized With COVID-19. JAMA Netw Open. 2022 Oct 3;5(10):e2238507. [cited 2022 Dec 15].","DOI":"10.1001\/jamanetworkopen.2022.38507"},{"key":"8324_CR25","unstructured":"Hill L, Artiga S, Rouw A, Kates J. How Equitable is Access to COVID-19 Treatments? [Internet]. 2022 [cited 2022 Nov 28];Available from: https:\/\/www.kff.org\/coronavirus-covid-19\/issue-brief\/how-equitable-is-access-to-covid-19-treatments\/."},{"key":"8324_CR26","doi-asserted-by":"publisher","unstructured":"Bogart LM, Ojikutu BO, Tyagi K, et al. COVID-19 Related Medical Mistrust, Health Impacts, and Potential Vaccine Hesitancy Among Black Americans Living With HIV. JAIDS J Acquir Immune Defic Syndr [Internet] 2021 [cited 2022 Nov 28];86(2):200\u20137. Available from: https:\/\/journals.lww.com\/https:\/\/doi.org\/10.1097\/QAI.0000000000002570.","DOI":"10.1097\/QAI.0000000000002570"},{"key":"8324_CR27","doi-asserted-by":"publisher","unstructured":"Williams DR, Wyatt R. Racial Bias in Health Care and Health: Challenges and Opportunities. JAMA [Internet] 2015 [cited 2022 Nov 28];314(6):555. Available from: http:\/\/jama.jamanetwork.com\/article.aspx?doi=https:\/\/doi.org\/10.1001\/jama.2015.9260.","DOI":"10.1001\/jama.2015.9260"},{"key":"8324_CR28","doi-asserted-by":"publisher","unstructured":"Jehi L, Ji X, Milinovich A, et al. Development and validation of a model for individualized prediction of hospitalization risk in 4,536 patients with COVID-19. PLOS ONE [Internet] 2020 [cited 2022 Mar 2];15(8):e0237419. Available from: https:\/\/dx.plos.org\/https:\/\/doi.org\/10.1371\/journal.pone.0237419.","DOI":"10.1371\/journal.pone.0237419"},{"issue":"7","key":"8324_CR29","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.16901","volume":"4","author":"TD Bennett","year":"2021","unstructured":"Bennett TD, Moffitt RA, Hajagos JG, et al. Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative. JAMA Netw Open 2021;4(7):e2116901.","journal-title":"JAMA Netw Open"},{"key":"8324_CR30","doi-asserted-by":"crossref","unstructured":"Razonable RR, Ganesh R, Bierle DM. Clinical Prioritization of Antispike Monoclonal Antibody Treatment of Mild to Moderate COVID-19. Mayo Clin Proc [Internet] 2022 [cited 2022 Nov 7];97(1):26\u201330. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619621008685.","DOI":"10.1016\/j.mayocp.2021.11.017"},{"key":"8324_CR31","doi-asserted-by":"publisher","unstructured":"Webb BJ, Levin NM, Grisel N, et al. Simple scoring tool to estimate risk of hospitalization and mortality in ambulatory and emergency department patients with COVID-19. PLOS ONE [Internet] 2022 [cited 2022 Nov 7];17(3):e0261508. Available from: https:\/\/dx.plos.org\/https:\/\/doi.org\/10.1371\/journal.pone.0261508.","DOI":"10.1371\/journal.pone.0261508"},{"key":"8324_CR32","doi-asserted-by":"publisher","unstructured":"Chow DS, Glavis-Bloom J, Soun JE, et al. Development and external validation of a prognostic tool for COVID-19 critical disease. PLOS ONE [Internet] 2020 [cited 2022 Nov 7];15(12):e0242953. Available from: https:\/\/dx.plos.org\/https:\/\/doi.org\/10.1371\/journal.pone.0242953.","DOI":"10.1371\/journal.pone.0242953"},{"key":"8324_CR33","unstructured":"Center for Disease Control. A Guide for Community Partners: Increasing COVID-19 Vaccine Uptake Among Members of Racial and Ethnic Minority Communities [Internet]. 2021 [cited 2022 Nov 28]. Available from: https:\/\/www.cdc.gov\/vaccines\/covid-19\/downloads\/guide-community-partners.pdf."},{"key":"8324_CR34","doi-asserted-by":"crossref","unstructured":"Chhibber A, Kharat A, Duong K, et al. Strategies to minimize inequity in COVID-19 vaccine access in the US: Implications for future vaccine rollouts. Lancet Reg Health - Am [Internet] 2022 [cited 2022 Nov 28];7:100138. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667193X21001344.","DOI":"10.1016\/j.lana.2021.100138"},{"key":"8324_CR35","doi-asserted-by":"publisher","unstructured":"Opel DJ, Lo B, Peek ME. Addressing Mistrust About COVID-19 Vaccines Among Patients of Color. Ann Intern Med [Internet] 2021 [cited 2022 Nov 28];174(5):698\u2013700. Available from: https:\/\/www.acpjournals.org\/doi\/https:\/\/doi.org\/10.7326\/M21-0055.","DOI":"10.7326\/M21-0055"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-023-08324-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-023-08324-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-023-08324-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T00:03:09Z","timestamp":1726358589000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-023-08324-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,15]]},"references-count":35,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["8324"],"URL":"https:\/\/doi.org\/10.1007\/s11606-023-08324-y","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,15]]},"assertion":[{"value":"27 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr Amin reported receiving grants from the University of California, Irvine, during the conduct of the study; grants from Alexion Pharmaceuticals, Blade Therapeutics, Eli Lilly and Company, Fulcrum Therapeutics, Humanigen, the National Institute of Allergy and Infectious Diseases, Novartis, NRx Pharmaceuticals, Octapharma, Pulmotect, PTC Therapeutics, and Takeda Pharmaceuticals; and personal fees from Achogen LaJolla, Alexion Pharmaceuticals, AseptiScope, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Company, Ferring Pharmaceuticals, Gilead Sciences, HeartRite, Millennium Pharmaceuticals, Mylan, Nabriva Therapeutics, Novartis, Paratek Pharmaceuticals, Pfizer, Portola Pharmaceuticals, Salix Pharmaceuticals, Seres Therapeutics, Spero Therapeutics, Sprightly Health, Sunovion Pharmaceuticals, and Tetraphase Pharmaceuticals outside the submitted work. Dr Bertagnolli reported receiving personal fees from The MITRE Corporation during the conduct of the study. Dr Chow reported receiving personal fees from Canon Medical Systems outside the submitted work. Dr Drews reported receiving grants from The MITRE Corporation during the conduct of the study and outside the submitted work. Dr Hanna reported receiving personal fees from Abpro Corporation and Merck & Co outside the submitted work. Dr Jones reported receiving personal fees from The MITRE Corporation during the conduct of the study. Dr Lopansri reported receiving personal fees from Seegene outside the submitted work. Dr O\u2019Horo reported receiving grants from The MITRE Corporation during the conduct of the study; grants from nference; and personal fees from Bates College outside the submitted work. Dr Piantadosi reported receiving personal fees from The MITRE Corporation during the conduct of the study and outside the submitted work. Dr Pritt reported receiving funding from The MITRE Corporation during the conduct of the study. Dr Razonable reported receiving grants from Gilead Sciences, Regeneron Pharmaceuticals, and Roche and personal fees from Novartis outside the submitted work. Dr Webb reported receiving grants from Gilead Sciences and Regeneron Pharmaceuticals outside the submitted work. No other disclosures were reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}